Literature DB >> 28927128

Expression of ING4 is negatively correlated with cellular proliferation and microvessel density in human glioma.

Bin Shao1, Enzhong Liu1.   

Abstract

The present study aimed to investigate the associations of tumor inhibitor of growth 4 (ING4) with tumor cell proliferation and microvessel density (MVD) in human glioma. Semi-quantitative reverse transcription polymerase chain reaction, western blotting and immunohistochemistry (IHC) were used to detect the level of ING4 expression in normal brain tissues and glioma tissues of different pathological grades. The cell proliferation index (PI) and the level of MVD were detected using IHC, facilitating the analysis of the correlation between ING4 and cellular proliferation and MVD in human glioma. The expression levels of ING4 mRNA and protein were significantly lower in the glioma tissues compared with the normal brain tissues (P<0.05) and decreased as the pathological grade of the glioma tissue increased (P<0.05). PI was reduced in the ING4 protein positively expressed (ING4+) glioma tissues compared with the ING4 protein negatively expressed (ING4-) glioma tissues (P≤0.01). The level of MVD was significantly higher in the glioma tissues than that in the normal brain tissues (P≤0.01), while the level of MVD decreased in the ING4+ glioma tissue compared with the ING4- glioma tissue (P≤0.001). A Spearman's rank correlation test revealed that ING4 protein expression was negatively correlated with PI and MVD. ING4 might inhibit tumor proliferation and angiogenesis in human glioma. The expression of ING4 was also associated with the pathological grading of the glioma tissue and negatively correlated with cellular proliferation and MVD in human glioma.

Entities:  

Keywords:  human glioma; microvessel density; proliferation index; tumor inhibitor of growth 4

Year:  2017        PMID: 28927128      PMCID: PMC5587956          DOI: 10.3892/ol.2017.6618

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.

Authors:  Jennifer M Rubatt; Kathleen M Darcy; Alan Hutson; Sarah M Bean; Laura J Havrilesky; Lisa A Grace; Andrew Berchuck; Angeles Alvarez Secord
Journal:  Gynecol Oncol       Date:  2009-01-09       Impact factor: 5.482

Review 2.  The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.

Authors:  Daniel J Brat; Anita C Bellail; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

3.  Magnetic resonance and fluorescence-protein imaging of the anti-angiogenic and anti-tumor efficacy of selenium in an orthotopic model of human colon cancer.

Authors:  Arup Bhattacharya; Steve G Turowski; Ivan Dominguez San Martin; Ashwani Rajput; Youcef M Rustum; Robert M Hoffman; Mukund Seshadri
Journal:  Anticancer Res       Date:  2011-02       Impact factor: 2.480

4.  Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma.

Authors:  Xiao-han Li; Keiji Kikuchi; Yang Zheng; Akira Noguchi; Hiroyuki Takahashi; Takeshi Nishida; Shinji Masuda; Xiang-hong Yang; Yasuo Takano
Journal:  Oral Oncol       Date:  2011-03       Impact factor: 5.337

5.  Crystal structure of inhibitor of growth 4 (ING4) dimerization domain reveals functional organization of ING family of chromatin-binding proteins.

Authors:  Simone Culurgioni; Inés G Muñoz; Alberto Moreno; Alicia Palacios; Maider Villate; Ignacio Palmero; Guillermo Montoya; Francisco J Blanco
Journal:  J Biol Chem       Date:  2012-02-09       Impact factor: 5.157

6.  Expression of tumor suppressor gene ING4 in ovarian carcinoma is correlated with microvessel density.

Authors:  Yinglan Liu; Liqian Yu; Yingwei Wang; Yaling Zhang; Yingchao Wang; Guangmei Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-08       Impact factor: 4.553

7.  Autophagy contributes to ING4-induced glioma cell death.

Authors:  Aihua Gong; Sisi Ye; Ermeng Xiong; Wenjie Guo; Yan Zhang; Wanxin Peng; Genbao Shao; Jie Jin; Zhijian Zhang; Jicheng Yang; Jing Gao
Journal:  Exp Cell Res       Date:  2013-05-14       Impact factor: 3.905

8.  Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.

Authors:  Feng Fang; Lai-Bang Luo; Yi-Ming Tao; Fan Wu; Lian-Yue Yang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02       Impact factor: 4.254

9.  Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy.

Authors:  C Ling; Y Xie; D Zhao; Y Zhu; J Xiang; J Yang
Journal:  Cancer Gene Ther       Date:  2012-08-03       Impact factor: 5.987

10.  [Expression and clinical significance of ING4 and HIF-1 alpha in brain astrocytoma].

Authors:  Shupeng Zhao; Cailing Jin; Xinli Zhao; Baozhe Jin; Lei Hui; Wenke Zhou; Guangming Niu; Shengzhong Tao
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2015-11-17
View more
  4 in total

Review 1.  Review on the Therapeutic Potential of Curcumin and its Derivatives on Glioma Biology.

Authors:  Malihe Mohamadian; Seyed Sajad Ahmadi; Afsane Bahrami; Gordon A Ferns
Journal:  Neurochem Res       Date:  2022-07-05       Impact factor: 4.414

2.  Enhanced effect of recombinant adenoviruses co-expression of ING4 and OSM on anti-tumour activity of laryngeal cancer.

Authors:  Fuwei Cheng; Shuangping Zhao; Jiachen Li; Yuyu Niu; Haiping Huang; Jicheng Yang; Shiyin Ma; Jisheng Liu; Peng Sun
Journal:  J Cell Mol Med       Date:  2022-01-24       Impact factor: 5.310

Review 3.  BRPF1-KAT6A/KAT6B Complex: Molecular Structure, Biological Function and Human Disease.

Authors:  Gaoyu Zu; Ying Liu; Jingli Cao; Baicheng Zhao; Hang Zhang; Linya You
Journal:  Cancers (Basel)       Date:  2022-08-23       Impact factor: 6.575

Review 4.  The essential role of tumor suppressor gene ING4 in various human cancers and non-neoplastic disorders.

Authors:  Yang Du; Yan Cheng; Guanfang Su
Journal:  Biosci Rep       Date:  2019-01-30       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.